MicroRNAs Involvement in Radioresistance of Head and Neck Cancer

Parwez Ahmad1, Jiri Sana2, Marek Slavik3

  • 1Central European Institute of Technology, Masaryk University, Brno, Czech Republic.

Disease Markers
|March 23, 2017
PubMed

Insights

MicroRNAs regulate key cancer processes, offering potential to overcome radiation resistance in head and neck cancers. Targeting microRNAs may improve treatment outcomes for these challenging tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Radioresistance is a significant challenge in treating head and neck cancers.
  • Mechanisms of radioresistance involve DNA repair, apoptosis, proliferation, and angiogenesis pathways.
  • MicroRNAs are key regulators of these complex cellular processes.

Purpose of the Study:

  • To review the role of microRNAs in cancer radioresistance.
  • To focus on the specific involvement of microRNAs in head and neck cancer radioresistance.
  • To highlight microRNAs as potential biomarkers and therapeutic targets.

Main Methods:

  • Literature review of studies on microRNAs and radioresistance.
  • Analysis of molecular mechanisms linking microRNAs to radiation response.
  • Focus on head and neck cancer-specific data.

Main Results:

  • MicroRNA deregulation is observed in various tumors, including head and neck cancer.
  • Specific microRNA expression patterns correlate with prognosis and therapeutic response.
  • MicroRNAs modulate critical pathways involved in radioresistance.

Conclusions:

  • MicroRNAs are crucial regulators of radioresistance in head and neck cancer.
  • MicroRNAs represent promising biomarkers for predicting treatment response.
  • Targeting microRNAs may offer novel strategies to enhance radiotherapy efficacy.